RCM
ENTX icon

RA Capital Management’s Entera Bio ENTX Stock Holding History

RA Capital Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-295,966
Closed -$343K – 56
2023
Q1 		$343K Hold
295,966
– – 0.01% 59
2022
Q4 		$216K Sell
295,966
-1,786,406
-86% -$1.29M ﹤0.01% 70
2022
Q3 		$2.17M Sell
2,082,372
-270,628
-12% -$408K 0.05% 75
2022
Q2 		$3.13M Hold
2,353,000
– – 0.08% 75
2022
Q1 		$6.75M Hold
2,353,000
– – 0.15% 86
2021
Q4 		$6.62M Hold
2,353,000
– – 0.12% 90
2021
Q3 		$11.1M Hold
2,353,000
– – 0.15% 72
2021
Q2 		$14.1M Buy
+2,353,000
New +$8.7M 0.23% 63

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RA Capital Management's ENTX Position: Q2 2023 in Review

RA Capital Management sold out of Entera Bio (ENTX) in Q2 2023, closing a stake of 295,966 shares — an estimated $343K sold.

RA Capital Management first reported a position in ENTX in Q2 2021 and held it in 8 quarters. The position peaked at $14.1M in Q2 2021. 12 funds tracked by Wall St. Rank hold ENTX as of Q2 2023.

  • RA Capital Management reported no remaining Entera Bio position as of Q2 2023 after selling out during the quarter.
  • RA Capital Management sold 295,966 Entera Bio shares in Q2 2023, an estimated $343K.
  • RA Capital Management first reported a position in Entera Bio in Q2 2021 and held it in 8 quarters.
  • RA Capital Management's Entera Bio position peaked at $14.1M in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Entera Bio as of Q2 2023.

Based on RA Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.